A large cohort study of more than 600,000 US veterans with type 2 diabetes found that initiating GLP-1 receptor agonists was ...

New research suggests the weight-loss medications could be powerful tools in tackling substance use disorders.

Research is quickly catching up. In the last few years, studies have linked GLP-1 drugs like Ozempic and Wegovy with fewer ...

Evidence is mounting that the wildly popular weight-loss medicines known as GLP-1s may also hold potential for treating ...

Evidence continues to mount suggesting that GLP-1 drugs like Ozempic and Wegovy may help people cut back on cigarettes, ...

A large epidemiological study of more than 600,000 veterans with diabetes suggests GLP-1 weight-loss medications may reduce ...

A large new study suggests they may drastically reduce the risk substance use disorders and drug-related deaths.

Scientists identify the protein DeltaFosB as the "master switch" that rewires the brain's memory and reward circuits, driving ...

Cocaine addiction isn’t simply a failure of willpower — it’s the result of lasting biological changes in the brain.

GLP-1 medications may quiet the brain signals behind addiction, reducing substance use disorders and overdose risk across ...

A new study found GLP-1 drugs were associated with 50% fewer substance-related deaths, 39% fewer drug overdoses, and 26% ...

FORT LAUDERDALE, FL - March 06, 2026 - PRESSADVANTAGE - Grace Point Treatment Center has published a new educational ...